YOKNEAM ILLIT, Israel,
March 24, 2014 /PRNewswire/ --
Syneron Medical Ltd. (Nasdaq: ELOS), a leading global aesthetic
device company, today announced that its Annual Report on Form
20-F, containing audited consolidated financial statements for the
year ended December 31, 2013, as
filed with the Securities and Exchange Commission on March 19, 2014, is available on its website
(www.syneron.com). Shareholders may receive a hard copy of the
annual report free of charge upon request. This press release is
being issued pursuant to NASDAQ Listing Rule 5250(d)(1)(C).
About Syneron Medical Ltd.
Syneron Medical Ltd.
(NASDAQ: ELOS) is a leading global aesthetic device company with a
comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide
advanced solutions for a broad range of medical-aesthetic
applications including body contouring, hair removal, wrinkle
reduction, rejuvenation of the skin's appearance through the
treatment of superficial benign vascular and pigmented lesions, and
the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela.
Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and
manufacturing operations in the US. The Company markets and
services and supports its products in 90 countries. It has offices
in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
Logo -
http://photos.prnewswire.com/prnh/20120528/535447
SOURCE Syneron Medical Ltd.